276 related articles for article (PubMed ID: 10092958)
1. Clinical pharmacokinetics of meloxicam. A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug.
Davies NM; Skjodt NM
Clin Pharmacokinet; 1999 Feb; 36(2):115-26. PubMed ID: 10092958
[TBL] [Abstract][Full Text] [Related]
2. Articular diffusion of meloxicam after a single oral dose: relationship to cyclo-oxygenase inhibition in synovial cells.
Lapicque F; Vergne P; Jouzeau JY; Loeuille D; Gillet P; Vignon E; Thomas P; Velicitat P; Türck D; Guillaume C; Gaucher A; Bertin P; Netter P
Clin Pharmacokinet; 2000 Nov; 39(5):369-82. PubMed ID: 11108435
[TBL] [Abstract][Full Text] [Related]
3. A review of the clinical pharmacokinetics of meloxicam.
Türck D; Roth W; Busch U
Br J Rheumatol; 1996 Apr; 35 Suppl 1():13-6. PubMed ID: 8630630
[TBL] [Abstract][Full Text] [Related]
4. Meloxicam: a reappraisal of pharmacokinetics, efficacy and safety.
Gates BJ; Nguyen TT; Setter SM; Davies NM
Expert Opin Pharmacother; 2005 Oct; 6(12):2117-40. PubMed ID: 16197363
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and safety of single and multiple oral doses of meloxicam in adult horses.
Noble G; Edwards S; Lievaart J; Pippia J; Boston R; Raidal SL
J Vet Intern Med; 2012; 26(5):1192-201. PubMed ID: 22860573
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics of meloxicam.
Türck D; Busch U; Heinzel G; Narjes H
Arzneimittelforschung; 1997 Mar; 47(3):253-8. PubMed ID: 9105543
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.
Schmid J; Busch U; Heinzel G; Bozler G; Kaschke S; Kummer M
Drug Metab Dispos; 1995 Nov; 23(11):1206-13. PubMed ID: 8591720
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacodynamic and pharmacokinetic aspects of the non-inflammatory non-steroidal agent meloxicam in dogs].
Poulsen Nautrup B; Hörstermann D
Dtsch Tierarztl Wochenschr; 1999 Mar; 106(3):94-100. PubMed ID: 10220944
[TBL] [Abstract][Full Text] [Related]
9. Single and multiple-dose pharmacokinetics of meloxicam after oral administration to the rabbit (Oryctolagus cuniculus).
Carpenter JW; Pollock CG; Koch DE; Hunter RP
J Zoo Wildl Med; 2009 Dec; 40(4):601-6. PubMed ID: 20063804
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of nabumetone. The dawn of selective cyclo-oxygenase-2 inhibition?
Davies NM
Clin Pharmacokinet; 1997 Dec; 33(6):404-16. PubMed ID: 9435990
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of lornoxicam. A short half-life oxicam.
Skjodt NM; Davies NM
Clin Pharmacokinet; 1998 Jun; 34(6):421-8. PubMed ID: 9646006
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor.
Davies NM; McLachlan AJ; Day RO; Williams KM
Clin Pharmacokinet; 2000 Mar; 38(3):225-42. PubMed ID: 10749518
[TBL] [Abstract][Full Text] [Related]
13. Meloxicam pharmacokinetics using nonlinear mixed-effects modeling in ferrets after single subcutaneous administration.
Chinnadurai SK; Messenger KM; Papich MG; Harms CA
J Vet Pharmacol Ther; 2014 Aug; 37(4):382-7. PubMed ID: 24483951
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous meloxicam suspension pharmacokinetics in mice and dose considerations for postoperative analgesia.
Chen PH; Boyd KL; Fickle EK; Locuson CW
J Vet Pharmacol Ther; 2016 Aug; 39(4):356-62. PubMed ID: 26896236
[TBL] [Abstract][Full Text] [Related]
15. Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration.
Euller-Ziegler L; Vélicitat P; Bluhmki E; Türck D; Scheuerer S; Combe B
Inflamm Res; 2001 Mar; 50 Suppl 1():S5-9. PubMed ID: 11339521
[TBL] [Abstract][Full Text] [Related]
16. Comparative plasma pharmacokinetics of meloxicam in sheep and goats following intravenous administration.
Shukla M; Singh G; Sindhura BG; Telang AG; Rao GS; Malik JK
Comp Biochem Physiol C Toxicol Pharmacol; 2007 May; 145(4):528-32. PubMed ID: 17395544
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of a Single Dose of Oral and Subcutaneous Meloxicam in Caribbean Flamingos ( Phoenicopterus ruber ruber).
Lindemann DM; Carpenter JW; KuKanich B
J Avian Med Surg; 2016 Mar; 30(1):14-22. PubMed ID: 27088740
[TBL] [Abstract][Full Text] [Related]
18. High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis.
Foeldvari I; Burgos-Vargas R; Thon A; Tuerck D
J Rheumatol; 2002 May; 29(5):1079-83. PubMed ID: 12022326
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of intravenous and oral meloxicam in ruminant calves.
Coetzee JF; KuKanich B; Mosher R; Allen PS
Vet Ther; 2009; 10(4):E1-8. PubMed ID: 20425727
[TBL] [Abstract][Full Text] [Related]
20. Meloxicam.
Khalil NY; Aldosari KF
Profiles Drug Subst Excip Relat Methodol; 2020; 45():159-197. PubMed ID: 32164967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
